Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: A randomised, double-blind, placebo-controlled pilot study.

Shuji Ikegami,Masanao Nakamura,Takashi Honda,Takeshi Yamamura,Keiko Maeda,Tsunaki Sawada,Eri Ishikawa,Kenta Yamamoto,Satoshi Furune,Takuya Ishikawa,Kazuhiro Furukawa,Eizaburo Ohno,Masatoshi Ishigami,Fumie Kinoshita,Yoshihiro Kadota,Takumi Tochio,Yoshiharu Shimomura,Yoshiki Hirooka,Hiroki Kawashima

Alimentary pharmacology & therapeutics（2023）

引用 2|浏览26

暂无评分

摘要

Oral 1-kestose is well tolerated and provides clinical improvement for patients with mild to moderate ulcerative colitis through modulation of the gut microbiome.

查看译文

关键词

1-kestose,prebiotics,ulcerative colitis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要